TRIAMCINOLONE HEXACETONIDE: 157 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
157
Total FAERS Reports
0
Deaths Reported
117
Hospitalizations
157
As Primary/Secondary Suspect
68
Life-Threatening
48
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Medexus Pharma, Inc.
Manufacturer
Discontinued
Status
Drug Class: Corticosteroid Hormone Receptor Agonists [MoA] · Route: INTRA-ARTICULAR · Manufacturer: Medexus Pharma, Inc. · FDA Application: 016466 · HUMAN PRESCRIPTION DRUG · FDA Label: Available
First Report: 19980321 · Latest Report: 20250902
What Are the Most Common TRIAMCINOLONE HEXACETONIDE Side Effects?
#1 Most Reported
Condition aggravated
91 reports (58.0%)
#2 Most Reported
Adrenal insufficiency
87 reports (55.4%)
#3 Most Reported
Septic shock
83 reports (52.9%)
All TRIAMCINOLONE HEXACETONIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Condition aggravated | 91 | 58.0% | 0 | 85 |
| Adrenal insufficiency | 87 | 55.4% | 0 | 86 |
| Arthritis | 83 | 52.9% | 0 | 82 |
| Drug ineffective | 83 | 52.9% | 0 | 82 |
| Obesity | 83 | 52.9% | 0 | 82 |
| Septic shock | 83 | 52.9% | 0 | 82 |
| Dizziness | 82 | 52.2% | 0 | 81 |
| Drug intolerance | 82 | 52.2% | 0 | 81 |
| Polyarthritis | 82 | 52.2% | 0 | 81 |
| Synovitis | 82 | 52.2% | 0 | 81 |
| Vomiting | 82 | 52.2% | 0 | 81 |
| Diarrhoea | 81 | 51.6% | 0 | 80 |
| Juvenile idiopathic arthritis | 81 | 51.6% | 0 | 80 |
| Nausea | 81 | 51.6% | 0 | 80 |
| Psoriasis | 81 | 51.6% | 0 | 80 |
| Human antichimeric antibody positive | 80 | 51.0% | 0 | 79 |
| C-reactive protein increased | 79 | 50.3% | 0 | 78 |
| Mobility decreased | 79 | 50.3% | 0 | 78 |
| Red blood cell sedimentation rate increased | 79 | 50.3% | 0 | 78 |
| Body height below normal | 78 | 49.7% | 0 | 77 |
Who Reports TRIAMCINOLONE HEXACETONIDE Side Effects? Age & Gender Data
Gender: 91.3% female, 8.7% male. Average age: 21.7 years. Most reports from: CA. View detailed demographics →
Is TRIAMCINOLONE HEXACETONIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 4 | 0 | 4 |
| 2013 | 1 | 0 | 0 |
| 2014 | 6 | 0 | 2 |
| 2015 | 2 | 0 | 0 |
| 2016 | 5 | 0 | 5 |
| 2017 | 1 | 0 | 1 |
| 2018 | 11 | 0 | 0 |
| 2019 | 3 | 0 | 3 |
| 2020 | 4 | 0 | 0 |
| 2021 | 16 | 0 | 4 |
| 2025 | 3 | 0 | 2 |
What Is TRIAMCINOLONE HEXACETONIDE Used For?
| Indication | Reports |
|---|---|
| Juvenile idiopathic arthritis | 90 |
| Rheumatoid arthritis | 36 |
| Osteoarthritis | 20 |
| Product used for unknown indication | 9 |
| Back pain | 5 |
TRIAMCINOLONE HEXACETONIDE vs Alternatives: Which Is Safer?
TRIAMCINOLONE HEXACETONIDE vs TRIAMTERENE
TRIAMCINOLONE HEXACETONIDE vs TRIATEC
TRIAMCINOLONE HEXACETONIDE vs TRIAZOLAM
TRIAMCINOLONE HEXACETONIDE vs TRICHLORMETHIAZIDE
TRIAMCINOLONE HEXACETONIDE vs TRICLOSAN
TRIAMCINOLONE HEXACETONIDE vs TRIENTINE
TRIAMCINOLONE HEXACETONIDE vs TRIENTINE TETRAHYDROCHLORIDE
TRIAMCINOLONE HEXACETONIDE vs TRIFAROTENE
TRIAMCINOLONE HEXACETONIDE vs TRIFLUOPERAZINE
TRIAMCINOLONE HEXACETONIDE vs TRIFLURIDINE
Other Drugs in Same Class: Corticosteroid Hormone Receptor Agonists [MoA]
Official FDA Label for TRIAMCINOLONE HEXACETONIDE
Official prescribing information from the FDA-approved drug label.